PolyNovo's brief is to make regenerative medicine devices and products based on a safe, polyurethane, biodegradable polymer. We listed on the ASX at 29 cents and we have a market cap of $160 million.
The products we are developing are based on a product called NovoSorb and NovoSorb was developed by the CSIRO. and we can make that out into a range of different products. We don't have any biological agents in our product at all compared to the products that are on the market, which are sourced from animal or cadaver skin.
We have an excellent bio-compatibility profile and safety profile for our products. Our BTM (Biodegradable Temporising Matrix) is a wound dressing intended for treatment of full-thickness wounds and burns where the dermal structure has been lost to trauma, or damaged requiring surgical removal.
